Table 2.
Pretreatment PSA.
| Mean | Median | Range (ng/mL) | |
|---|---|---|---|
| Hypofractionated group | |||
| All patients | 10.45 | 34.90 | 0.02–61.72 |
| RT only | 6.93 | 6.84 | 3.20–11.0 |
| RT + ADT | 12.10 | 7.50 | 0.02–61.72 |
| Comparative 3D-CRT group | |||
| RT only | 7.74 | 7.39 | 3.80–12.77 |
Pretreatment PSA.
| Mean | Median | Range (ng/mL) | |
|---|---|---|---|
| Hypofractionated group | |||
| All patients | 10.45 | 34.90 | 0.02–61.72 |
| RT only | 6.93 | 6.84 | 3.20–11.0 |
| RT + ADT | 12.10 | 7.50 | 0.02–61.72 |
| Comparative 3D-CRT group | |||
| RT only | 7.74 | 7.39 | 3.80–12.77 |